Research and development of model radiopharmaceuticals labelled with beta and positron emitting radioisotopes and used for a tumour therapy and detection of metastatic lesions. (KMOP-1.1.1-08/1-2008-0017)
Financing:
The project was co-financed by the European Regional development Fund (ERDF)